Loading…
Based on limited metadata, this FDA Warning Letter issued to LZD Investments LLC on February 9, 2018, involves a product classified as "Other" (specific product type not detailed in available metadata). Without access to the full letter text or subject line, the precise nature of the violations cannot be determined from the available information. The issuing office is not specified in the metadata, which limits clarity on the specific regulatory program or division involved in this enforcement action. To understand the full scope and details of the violations, the complete FDA Warning Letter would need to be reviewed.